Clinical trial
Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)
NCT02716532 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- November 15, 2017
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
injuries, acute brain, severe trauma brain injury (stbi), subarachnoid hemorrhage, aneurysmal